If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 65   2004   NUMBER 1

Issue to be mailed the week of February 5, 2004

CME Pretest 3

CME Posttest 140

Editorial

4 Our Reviewers. Alan J. Gelenberg
[PDF]

Brainstorms

8 Symptoms and Circuits, Part 3: Schizophrenia. Stephen M. Stahl
[PDF]

Original Articles

10 Glycogen Synthase Kinase-3: A Target for Novel Bipolar Disorder Treatments. Todd D. Gould, Carlos A. Zarate, and Husseini K. Manji
[Abstract] [PDF]

22 Impact of Age at Onset and Duration of Illness on the Expression of Comorbidities in Obsessive-Compulsive Disorder. [CME] Juliana B. Diniz, Maria C. Rosario-Campos, Roseli G. Shavitt, Mariana Curi, Ana G. Hounie, Sergio A. Brotto, and Euripedes C. Miguel
[Abstract] [PDF]

28 Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years. Mary C. Zanarini, Frances R. Frankenburg, John Hennen, and Kenneth R. Silk
[Abstract] [PDF]

37 A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder. Damiaan Denys, Harold J. G. M. van Megen, Nic van der Wee, and Herman G. M. Westenberg
[Abstract] [PDF]

44 Escitalopram Continuation Treatment Prevents Relapse of Depressive Episodes. Mark Hyman Rapaport, Anjana Bose, and Hongjie Zheng
[Abstract] [PDF]

50 Zonisamide in the Treatment of Binge-Eating Disorder: An Open-Label, Prospective Trial. Susan L. McElroy, Renu Kotwal, James I. Hudson, Erik B. Nelson, and Paul E. Keck, Jr.
[Abstract] [PDF]

57 Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol. Jan Volavka, Pal Czobor, Thomas B. Cooper, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P. McEvoy, and Jeffrey A. Lieberman
[Abstract] [PDF]

62 A Placebo-Controlled Trial of Bupropion SR as an Antidote for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction. Anita H. Clayton, Julia K. Warnock, Susan G. Kornstein, Relana Pinkerton, Adrienne Sheldon-Keller, and Elizabeth L. McGarvey
[Abstract] [PDF]

68 Single-Dose Intravenous Valproate in Acute Mania. Katrina Phrolov, Julia Applebaum, Joseph Levine, Hanoch Miodovnick, and R. H. Belmaker
[Abstract] [PDF]

71 In the Puerperium, Primiparae Exhibit Higher Levels of Anxiety and Serum Peptidase Activity and Greater Immune Responses Than Multiparae. Michael Maes, Eugene Bosmans, and Willem Ombelet
[Abstract] [PDF]

77 Lifetime History of Sexual Abuse, Clinical Presentation, and Outcome in a Clinical Trial for Adolescent Depression. Rémy P. Barbe, Jeffrey A. Bridge, Boris Birmaher, David J. Kolko, and David A. Brent
[Abstract] [PDF]

84 Gabapentin Reduces Cocaine Use Among Addicts From a Community Clinic Sample. Wilfrid Noel Raby and Siobhan Coomaraswamy
[Abstract] [PDF]

87 One-Year Follow-Up After Successful ECT: A Naturalistic Study in Depressed Inpatients. Tom K. Birkenhäger, Jan-Willem Renes, and Esther M. Pluijms
[Abstract] [PDF]

92 Branched Chain Amino Acid Treatment of Tardive Dyskinesia in Children and Adolescents. Mary Ann Richardson, Arthur M. Small, Laura L. Read, Helen M. Chao, and James D. Clelland
[Abstract] [PDF]

97 An Open-Label Trial of Sildenafil Addition in Risperidone-Treated Male Schizophrenia Patients With Erectile Dysfunction. Alex Aviv, Assaf Shelef, and Abraham Weizman
[Abstract] [PDF]

104 Olanzapine Versus Placebo in the Treatment of Borderline Personality Disorder. Michael P. Bogenschutz and H. George Nurnberg
[Abstract] [PDF]

110 The Effect of a Switch to Ziprasidone in an Adult Population With Autistic Disorder: Chart Review of Naturalistic, Open-Label Treatment. Seth A. Cohen, Brian J. Fitzgerald, Shirin R. F. Khan, and Arif Khan
[Abstract] [PDF]

114 A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome. Clive G. Ballard, Alan Thomas, Jane Fossey, Lesley Lee, Robin Jacoby, Marisa M. Lana, Carol Bannister, Rupert McShane, Alan Swann, Ed Juszczak, and John T. O'Brien
[Abstract] [PDF]

Academic Highlights

120 Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics. [CME]
[Abstract] [PDF]

Letters To the Editor

132 Hypomanic Episodes After Receiving Ziprasidone: An Unintended "On-Off-On" Course of Treatment. Peter Brieger
[PDF]

132 Worsened Agitation With Aripiprazole: Adverse Effect of Dopamine Partial Agonism? John R. DeQuardo
[PDF]

133 Possible Role of Divalproex Sodium in Sedation Induced by Antipsychotic Medications. Timothy R. Berigan
[PDF]

134 Valproate for Hostility in Schizophrenia Patients. Kimberly H. Littrell, Richard G. Petty, Nicole M. Hilligoss, Carol D. Kirshner, and Craig G. Johnson
[PDF]

134 Use of Propofol for Alcohol Withdrawal Delirium: A Case Report. Junji Takeshita
[PDF]

135 Two Cases of Perospirone-Induced Mania in Schizophrenia. Takayuki Yokoshima, Nori Takei, Kunihiko Tani, Masayoshi Kawai, Yosho Minabe, and Norio Mori
[PDF]

Book Reviews 136

Worldview of Psychiatry 138

NOW@Psychiatrist.com 142

Information for authors

see www.psychiatrist.com/author.htm for complete information